Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

News > All

Total search results: 12050 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. 2019-10-10
BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. 2019-10-10
Agilent Technologies Inc.. (10/9/19). "Press Release: Agilent Opens State-of-the-Art Spectroscopy Site in the UK". Santa Clara, CA. 2019-10-09
Bluebird Bio, Inc.. (10/9/19). "Press Release: Bluebird Bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases". Cambridge, MA & Bagsvaerd. 2019-10-09
N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. 2019-10-09
Evotec SE. (10/9/19). "Press Release: Evotec and Celmatix Enter into Strategic Collaboration". Hamburg & New York, NY. 2019-10-09
Flagship Pioneering. (10/8/19). "Press Release: Flagship Pioneering Unveils Cygnal Therapeutics. Company Is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More". Cambridge, MA. 2019-10-08
Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto. 2019-10-08
GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA. 2019-10-08
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. 2019-10-07
Korro Bio, Inc.. (10/7/19). "Press Release: Korro Bio Launched to Advance Groundbreaking New Approach to Nucleic Acid Editing". Cambridge, MA. 2019-10-07
MiroBio Ltd.. (10/7/19). "Press Release: MiroBio Launches with £27m ($34m) Series A from Leading Life Sciences Investors". Oxford. 2019-10-07
Dalhousie University. (10/7/19). "Press Release: Molly Appeal to Help Fund Orbitrap Fusion, Boosting Cancer, Brain, Immunity Research". 2019-10-07
Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. 2019-10-07
Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire. 2019-10-05
Immunexpress, Inc.. (10/3/19). "Press Release: Immunexpress Announces Closing of Private Funding Round". Seattle, WA. 2019-10-03
Aeovian Pharmaceuticals Inc.. (10/3/19). "Press Release: Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases". San Francisco, CA. 2019-10-03
Geneoscopy, Inc.. (10/2/19). "Press Release: Geneoscopy Raises $6.9 Million to Advance Preventive Screening Test for Colorectal Cancer and Advanced Adenomas". St. Louis, MO. 2019-10-02
Blueprint Genetics Oy. (10/2/19). "Press Release: Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness Launch an Open Access Program for Patients with Inherited Retinal Disease in the United States". 2019-10-02
Frequency Therapeutics, Inc.. (10/2/19). "Press Release: Frequency Therapeutics Announces Pricing of Initial Public Offering". Woburn, MA. 2019-10-02
Genomenon, Inc.. (10/2/19). "Press Release: Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform". Ann Arbor, MI. 2019-10-02
Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA. 2019-10-02
ADC Therapeutics S.A.. (10/2/19). "Press Release: ADC Therapeutics Announces Withdrawal of Registration Statement". Lausanne. 2019-10-02
Elicio Therapeutics. (10/2/19). "Press Release: Elicio Therapeutics Completes $33 Million Series B Financing". Cambridge, MA. 2019-10-02
SEngine Precision Medicine. (10/2/19). "Press Release: SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform". Seattle, WA. 2019-10-02
Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg. 2019-10-02
Adaptimmune Ltd.. (10/1/19). "Press Release: Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer". Philadeliphia, PA & Oxfordshire. 2019-10-01
Novartis AG. (10/1/19). "Press Release: Novartis and Microsoft Announce Collaboration to Transform Medicine with Artificial Intelligence". Basel & Redmond, WA. 2019-10-01
Bayer AG. (10/1/19). "Press Release: Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio". Monheim, Boston, MA & New Haven, CT. 2019-10-01
Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY. 2019-10-01
Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich). 2019-09-30
Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. 2019-09-30
BCNP Consultants GmbH. (9/27/19). "Press Release: 2nd ECP Summer Summit at Henkel HQ, Düsseldorf". Düsseldorf & Frankfurt a. M.. 2019-09-27
BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". 2019-09-27
AMETEK, Inc.. (9/27/19). "Press Release: Ametek to Acquire Gatan from Roper Technologies". Berwyn, PA & Sarasota, FL. 2019-09-27
Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA. 2019-09-26
Deerfield Management Company L.P.. (9/26/19). "Press Release: Deerfield Management Brings Together Scientists, Entrepreneurs and Leading Companies to Form the New York-Based Healthcare Innovation Campus". New York, NY. 2019-09-26
Thermo Fisher Scientific Inc.. (9/25/19). "Press Release: Thermo Fisher Scientific Prices Offering of Senior Notes". Waltham, MA. 2019-09-25
Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin. 2019-09-25
MolPort. (9/24/19). "Press Release: MolPort Expansion Enables more Efficient Compound and Reagent Sourcing in the USA". Riga. 2019-09-24
Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. 2019-09-24
Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". 2019-09-24
BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz. 2019-09-24
Addex Therapeutics S.A.. (9/24/19). "Press Release: Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares". Geneva. 2019-09-24
Fluidic Analytics Ltd.. (9/23/19). "Press Release: Fluidic Analytics Welcomes Dr Joe Keegan as Chairman". 2019-09-23
Cerevel Therapeutics, LLC. (9/23/19). "Press Release: Cerevel Therapeutics Announces Positive Results from a Phase 2 Study of Tavapadon in Patients with Early-stage Parkinson’s Disease". Boston, MA. 2019-09-23
Flagship Pioneering. (9/23/19). "Press Release: Flagship Pioneering Unveils Omega Therapeutics and Appoints Seasoned BioPharma Executive Mahesh Karande as President and Chief Executive Officer". Cambridge, MA. 2019-09-23
Illumina, Inc.. (9/23/19). "Press Release: Illumina Names Joydeep Goswami Senior Vice President of Corporate Development and Strategic Planning". San Diego, CA. 2019-09-23
ADC Therapeutics S.A.. (9/23/19). "Press Release: ADC Therapeutics Announces Launch of Initial Public Offering". Lausanne. 2019-09-23
AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. 2019-09-20
Bruker Corporation. (9/20/19). "Press Release: Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping". Perth & Billerica, MA. 2019-09-20
Roche. (9/20/19). "Press Release: FDA Approves cobas Babesia, Roche’s First Whole Blood Test for Donor Screening". Basel. 2019-09-20
Innate Pharma S.A.. (9/20/19). "Press Release: Innate Pharma Files Registration Statement for Proposed Initial Public Offering in the United States". Marseille. 2019-09-20
Boehringer Ingelheim. (9/20/19). "Press Release: Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases". Ingelheim & Newton, MA. 2019-09-20
Menarini Silicon Biosystems S.p.A.. (9/19/19). "Press Release: Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee". Bologna. 2019-09-19
Ginkgo Bioworks Inc.. (9/19/19). "Press Release: Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming". Boston, MA. 2019-09-19
Boundless Bio. (9/19/19). "Press Release: Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA". San Diego, CA. 2019-09-19
Agilent Technologies Inc.. (9/19/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hualiang Jiang". Santa Clara, CA. 2019-09-19
Exagen Inc.. (9/18/19). "Press Release: Exagen Inc. Announces Pricing of Initial Public Offering". San Diego, CA. 2019-09-18
Agilent Technologies Inc.. (9/18/19). "Press Release: Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share". Santa Clara, CA. 2019-09-18
Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel. 2019-09-18
Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. 2019-09-18
CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. 2019-09-17
SpringWorks Therapeutics, Inc.. (9/17/19). "Press Release: SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares". Stamford, CT. 2019-09-17
Jounce Therapeutics, Inc.. (9/17/19). "Press Release: Jounce Therapeutics Names Jacquelyn Fahey Sandell as Chief Legal Officer and Corporate Secretary". Cambridge, MA. 2019-09-17
TwoXar, Inc.. (9/17/19). "Press Release: TwoXar Announces Appointment of Allen Poirson, Ph.D. as Senior Vice President of Biopharmaceutical Business Development". Mountain View, CA. 2019-09-17
Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. 2019-09-17
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
Procarta Biosystems Ltd.. (9/17/19). "Press Release: Procarta Receives CARB-X Award of up to $9.2 million". Stevenage. 2019-09-17
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2019-09-16
PPF Group N.V.. (9/16/19). "Press Release: PPF Expands Its Investment in the Healthcare Sector through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics". 2019-09-16
10x Genomics Inc.. (9/16/19). "Press Release: 10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares". Pleasanton, CA. 2019-09-16
H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA. 2019-09-16
Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. 2019-09-16
SpringWorks Therapeutics, Inc.. (9/12/19). "Press Release: SpringWorks Therapeutics Announces Pricing Of Initial Public Offering". Stamford, CT. 2019-09-12
Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. 2019-09-12
Healthy.io Ltd.. (9/12/19). "Press Release: Healthy.io Raises $60 Million in Series C Funding and Receives FDA Clearance for Smartphone-Based Test to Diagnose Chronic Kidney Disease". Tel Aviv. 2019-09-12
10x Genomics Inc.. (9/12/19). "Press Release: 10x Genomics Announces Pricing of Initial Public Offering". Pleasanton, CA. 2019-09-12
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Atomwise, Inc.. (9/11/19). "Press Release: Atomwise and Atropos Launch Joint Venture to Discover Senescence Modulating Small Molecules for Cancer Patients". San Francisco, CA & Belmont, CA. 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Atomwise Announces Largest China-US Collaboration for AI Drug Discovery". San Francisco, CA. 2019-09-11
Waters Corporation. (9/11/19). "Press Release: Mark Beaudouin to Retire as Waters General Counsel, Company Promotes Keeley Aleman". Milford, MA. 2019-09-11
o2h Discovery. (9/11/19). "Press Release: Cedilla Therapeutics and o2h Discovery Are Pleased to Announce Multi FTE Expansion to Their Synthetic Chemistry Collaboration". Cambridge & Cambridge, MA. 2019-09-11
UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA. 2019-09-11
Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. 2019-09-11
Avalon Ventures. (9/11/19). "Press Release: Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK". San Diego, CA. 2019-09-11
Insilico Medicine. (9/10/19). "Press Release: Insilico Medicine Secures $37m in Series B Funding Led by Qiming Venture Partners". Hong Kong. 2019-09-10
Atomwise, Inc.. (9/10/19). "Press Release: Atomwise and OncoStatyx Announce Joint Venture to Develop Small Molecule Inhibitors of Oncology Target KDM5B". San Francisco, CA & Cleveland, OH. 2019-09-10
Atomwise, Inc.. (9/10/19). "Press Release: SEngine Precision Medicine and Atomwise Announce Strategic Joint Venture to Accelerate Novel Drug Discovery". Seattle, WA & San Francisco, CA. 2019-09-10
Pharvaris B.V.. (9/10/19). "Press Release: Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema". Leiden. 2019-09-10
Mibilion Systems, Inc.. (9/10/19). "Press Release: Mobilion Introduces its First Ion Mobility Product in Partnership with Agilent to Provide Unprecedented Separation and Mass Spectrometry Capabilities". Chadds Ford, PA. 2019-09-10
Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. 2019-09-10
Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. 2019-09-10
BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. 2019-09-09
Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. 2019-09-09
Cerevel Therapeutics, LLC. (9/9/19). "Press Release: Cerevel Therapeutics Appoints Biotechnology Leader Tony Coles, M.D., as Chief Executive Officer". Boston, MA. 2019-09-09
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
Eli Lilly and Company. (9/9/19). "Press Release: Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Canc 2019-09-09
Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. 2019-09-09
1 2 3 ... 119 120 121  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top